Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy.

Saved in:
Bibliographic Details
Title: Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy.
Authors: Vilaseca A; Department of Neurology and MS Centre of Catalonia (Cemcat), Vall D'hebron University Hospital, Barcelona, Spain.; Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Ariño H; Department of Neurology and MS Centre of Catalonia (Cemcat), Vall D'hebron University Hospital, Barcelona, Spain.; Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Iacoboni G; Hematology Department, Vall D'hebron University Hospital, Barcelona, Spain., Feijóo S; Hematology Department, Vall D'hebron University Hospital, Barcelona, Spain., Zabalza A; Department of Neurology and MS Centre of Catalonia (Cemcat), Vall D'hebron University Hospital, Barcelona, Spain.; Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Fissolo N; Department of Neurology and MS Centre of Catalonia (Cemcat), Vall D'hebron University Hospital, Barcelona, Spain.; Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Arévalo MJ; Department of Neurology and MS Centre of Catalonia (Cemcat), Vall D'hebron University Hospital, Barcelona, Spain.; Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Carpio C; Hematology Department, Vall D'hebron University Hospital, Barcelona, Spain., Sánchez M; Hematology Department, Vall D'hebron University Hospital, Barcelona, Spain., Tintoré M; Department of Neurology and MS Centre of Catalonia (Cemcat), Vall D'hebron University Hospital, Barcelona, Spain.; Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Universitat de Vic-Universitat Central de Catatlunya (UVic-UCC), Vic, Spain., Comabella M; Department of Neurology and MS Centre of Catalonia (Cemcat), Vall D'hebron University Hospital, Barcelona, Spain.; Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Montalban X; Department of Neurology and MS Centre of Catalonia (Cemcat), Vall D'hebron University Hospital, Barcelona, Spain.; Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Universitat de Vic-Universitat Central de Catatlunya (UVic-UCC), Vic, Spain., Barba P; Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Hematology Department, Vall D'hebron University Hospital, Barcelona, Spain., Vidal-Jordana Á; Department of Neurology and MS Centre of Catalonia (Cemcat), Vall D'hebron University Hospital, Barcelona, Spain.; Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Source: European journal of neurology [Eur J Neurol] 2025 Aug; Vol. 32 (8), pp. e70305.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print Cited Medium: Internet ISSN: 1468-1331 (Electronic) Linking ISSN: 13515101 NLM ISO Abbreviation: Eur J Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1468-1331
DOI:10.1111/ene.70305